Farallon Capital Partners, L.P. 13D/13G Filings for Tango Therapeutics, Inc. (TNGX)

Farallon Capital Partners, L.P. 13D and 13G filings for Tango Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-06-13
5:25 pm
Purchase
2025-06-06 13G Tango Therapeutics, Inc.
TNGX
Farallon Capital Partners, L.P. 7,182,000
6.600%
7,182,000increase
(New Position)
Filing